Clinical human trials begin for COVID-19 vaccine in China

[JSCh]

Big congratulations to #PKU researcher Cao Yunlong, who's among @Nature's 10 people who helped shape science. Cao is on the list for “his rich characterizations of emerging variants,” which have “allowed researchers to keep step with SARS-CoV-2 as it evolves.” @yunlong_cao
Cao is a researcher at #PKU's Biomedical Pioneering Innovation Centre and a leading member of a research team led by PKU Prof. Xiaoliang Sunney Xie. Nature's 10 list 2022 explores “key developments in science”&“some of the people who played important parts in these milestones.”

https://twitter.com/x/status/1603263866451898368

https://twitter.com/x/status/1603075974249299968

 

[JSCh]

1st batch of our Inhaled #COVID-19 Vaccine #Convidecia Air™ has arrived in #Morocco, providing an innovative solution to support and accelerate the building of mass immune protection. It is the second country that has approved and started rolling out our inhaled vaccine.
For more information, please visit: https://cansinotech.com/html/1///179/180/1131.html

https://twitter.com/x/status/1607700461750190081

 

[Han Patriot]

LATEST UPDATE emergency ward overwhelmed, bodies everywhere.

 

[JSCh]

#Sinopharm's F61 nasal spray received clinical trial approval from Chinese national medical authority for people at high risk of exposure to the novel coronavirus. It will be an important weapon in the fight against the rapidly spreading #Omicron variant.
https://globaltimes.cn/page/202211/1280675.shtml

https://twitter.com/x/status/1597264243195146241

郑镐溶​

22-12-28 17:47​

发布于 福建​

来自 iPhone 11 Pro Max​

已编辑​

关注​

国药研发的F61单抗喷雾，开始上市销售了，对奥密克戎BA.5、BF.7有效​

Zheng Haorong
22-12-28 17:47 Posted in Fujian
From iPhone 11 Pro Max

The F61 monoclonal antibody spray developed by Sinopharm is now on the market and is effective for Omicron BA.5 and BF.7

 

[JSCh]

A report on the therapeutic effect of China’s first COVID-19 oral drug VV116 was released Tuesday.

It concluded that confirmed patients receiving the drug within five days of their first positive test saw better treatment results. https://bit.ly/39wad4K

https://twitter.com/x/status/1527174715927838722

Interesting study showing an oral version of #remdesivir (VV16) works as well as #Paxlovid for reducing COVID symptoms (no severe illness or deaths in either group), but has fewer side effects. 1/

https://twitter.com/x/status/1608289782924197939

https://twitter.com/x/status/1608223774004097024

 

[JSCh]

China has approved the import of US pharma giant MSD's Covid-19 drug #Molnupiravir with certain conditions attached, the National Medical Products Administration said yesterday. The medicine is used to treat mild-to-moderate cases of #COVID19 in adults.
@Merck

https://twitter.com/x/status/1608748572131921923

 

[JSCh]

#SA58, a new anti-COVID-19 monoclonal antibody nasal spray developed by #Sinovac, has shown favorable efficacy in preventing #COVID19 infection, said two preliminary reports.

https://twitter.com/x/status/1610712671464177699

https://twitter.com/x/status/1610300631503314951

 

[JSCh]

CanSino Gains as Clinical Trials Show Its mRNA Covid Vaccine Is Effective Against Major Variants

https://twitter.com/x/status/1611268879828893696

 

[aziqbal]

Interesting study showing an oral version of #remdesivir (VV16) works as well as #Paxlovid for reducing COVID symptoms (no severe illness or deaths in either group), but has fewer side effects. 1/

https://twitter.com/x/status/1608289782924197939

https://twitter.com/x/status/1608223774004097024

https://twitter.com/x/status/1609818903273771010

 

[JSCh]

Pan-vaccine antigen strategy confers protection against cross-clade SARS-CoV-2 variants, including vaccine-resistant Omicron variants https://news-medical.net/news/20230106/Pan-vaccine-antigen-strategy-confers-protection-against-cross-clade-SARS-CoV-2-variants-including-vaccine-resistant-Omicron-variants.aspx…

https://twitter.com/x/status/1611377203773677576

“Our results highlight the importance and feasibility of a universal vaccine to fight against SARS-CoV-2 antigenic drift.”
@ScienceTM

https://twitter.com/x/status/1611449311119679494

 

[JSCh]

China's Cosunter Pharma Soars After #COVID19 Drug Proves Better Than Paxlovid

https://twitter.com/x/status/1612765188771512321

 

[JSCh]

China approves first domestic #mRNA #vaccine for COVID-19

https://twitter.com/x/status/1638465546256523265